Not Yet Recruiting
CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors
NCT06647329
- Conditions
- CAR-T Cell Therapy, Disease Attributes, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- the First Hospital of Zhengzhou University Zhengzhou, Henan, China